9-ING-41 in Patients With Advanced Cancers
Clinical trial NCT03678883 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03678883
- Sponsor
- Actuate Therapeutics Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-04
- Primary completion
- 2026-06-01
- Enrollment
- 350
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.